Semaglutide is a proven, FDA-approved GLP-1 agonist for weight loss (1520% body weight reduction in clinical trials) Tirzepatide is a dual GIP/GLP-1 agonist showing up to 22% weight loss in trials often more potent than Semaglutide for some patients Retatrutide is an experimental triple agonist with promising early results, but is NOT FDA-approved and not yet available at Better Med Spa All three require medical supervision, lifestyle changes, and ongoing monitoring for safe, sustainable results Better Med Spa in Lincoln Park currently offers Semaglutide and Tirzepatide with physician-directed protocols, slow titration, and holistic wellness integration Quick Comparison: Semaglutide vs
Documented hypersensitivity to a product component
This powder supplement is vegan, gluten-free, dairy-free, soy-free, and keto-friendly, with no artificial flavors, colors, sweeteners, or preservatives
Dosage and Administration Guidelines Recommended Dosage 10mg once weekly , or as prescribed by a qualified healthcare provider Administration Method Subcutaneous injection into the abdomen, thigh, or upper arm Rotate injection sites to reduce irritation Treatment Duration Can be used long-term , including up to several years, under medical supervision Consistent weekly dosing is essential to maintain steady therapeutic levels and achieve optimal results safely
REFERENCES Sims E et al, Endocrine and metabolic effects of experimental obesity in man
the estimated ratio of AUC 0inf was 1.03 and the 90% CI (0.961.11) was within the prespecified no effect interval (Fig
